Total Domestic Import Volume 726,000 Doses... 210,000 Doses Used as of the 17th

[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Kim Young-won] An additional 102,000 doses of Paxlovid will be introduced into the country on the 18th.


The Central Disease Control Headquarters announced that 102,000 doses of Pfizer's oral COVID-19 treatment Paxlovid will arrive in the country on this day. Adding this to the 624,000 doses of Paxlovid previously introduced, the total domestic supply of Paxlovid will reach 726,000 doses.


As of the 17th, 210,000 doses of Paxlovid have been used, with 414,000 doses remaining in stock. Including the doses arriving on the 18th, the total stock will be 516,000 doses.


The domestic supply of MSD's oral COVID-19 treatment Lagevrio is 100,000 doses. As of the 17th, 13,000 doses have been administered, and 87,000 doses remain.



A spokesperson from the Central Disease Control Headquarters stated, "We will strive to secure sufficient oral treatments to support the transition to the general healthcare system."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing